Osteoporosis and Related Bone Metabolic Disease / / edited by Heinrich Resch.
Many heterogeneous causes (e.g., metabolic, inflammatory, autoimmune, vascular, and renal diseases, and even drugs), collectively grouped as secondary causes of osteoporosis, may lead to bone loss or damage to architecture through a number of mechanisms. Although these secondary causes of osteoporos...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023. |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (164 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993599255004498 |
---|---|
ctrlnum |
(CKB)5700000000354292 (NjHacI)995700000000354292 (EXLCZ)995700000000354292 |
collection |
bib_alma |
record_format |
marc |
spelling |
Osteoporosis and Related Bone Metabolic Disease / edited by Heinrich Resch. Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, 2023. 1 online resource (164 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Many heterogeneous causes (e.g., metabolic, inflammatory, autoimmune, vascular, and renal diseases, and even drugs), collectively grouped as secondary causes of osteoporosis, may lead to bone loss or damage to architecture through a number of mechanisms. Although these secondary causes of osteoporosis are the most frequently observed causes of unexpected bone loss, they can only be diagnosed via a high degree of suspicion and clinical experience and by performing the appropriate investigations. In inflammatory disorders such as rheumatoid arthritis or chronic inflammatory bowel diseases, as well as vascular diseases, T-cell activation, and consequently pro-inflammatory cascades, trigger the increased expression of T-cell-derived RANKL. In addition, a new biomarker signature of bone-related miRNAs is promising in certain clinical features. Glucocorticoids, often used to control disease activity, decrease the number and function of osteoblasts and inhibit OPG expression. The ubiquitous occurrence of disease-related secondary changes in bone metabolism implies that numerous medical disciplines need to interact. Screening for secondary causes of osteoporosis and the search for new modes of action should present a substantial aspect of osteoporosis manageme. Bones Metabolism Disorders. Osteoporosis Genetic aspects. 3-0365-6348-2 Resch, Heinrich, editor. |
language |
English |
format |
eBook |
author2 |
Resch, Heinrich, |
author_facet |
Resch, Heinrich, |
author2_variant |
h r hr |
author2_role |
TeilnehmendeR |
title |
Osteoporosis and Related Bone Metabolic Disease / |
spellingShingle |
Osteoporosis and Related Bone Metabolic Disease / |
title_full |
Osteoporosis and Related Bone Metabolic Disease / edited by Heinrich Resch. |
title_fullStr |
Osteoporosis and Related Bone Metabolic Disease / edited by Heinrich Resch. |
title_full_unstemmed |
Osteoporosis and Related Bone Metabolic Disease / edited by Heinrich Resch. |
title_auth |
Osteoporosis and Related Bone Metabolic Disease / |
title_new |
Osteoporosis and Related Bone Metabolic Disease / |
title_sort |
osteoporosis and related bone metabolic disease / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2023 |
physical |
1 online resource (164 pages) |
isbn |
3-0365-6349-0 3-0365-6348-2 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC931 |
callnumber-sort |
RC 3931 M45 O884 42023 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.7/16042 |
dewey-sort |
3616.7 516042 |
dewey-raw |
616.7/16042 |
dewey-search |
616.7/16042 |
work_keys_str_mv |
AT reschheinrich osteoporosisandrelatedbonemetabolicdisease |
status_str |
n |
ids_txt_mv |
(CKB)5700000000354292 (NjHacI)995700000000354292 (EXLCZ)995700000000354292 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Osteoporosis and Related Bone Metabolic Disease / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653152475283457 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02297nam a2200301 i 4500</leader><controlfield tag="001">993599255004498</controlfield><controlfield tag="005">20230703202421.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230703s2023 sz o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-0365-6349-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000354292</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000354292</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000354292</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC931.M45</subfield><subfield code="b">.O884 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.7/16042</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Osteoporosis and Related Bone Metabolic Disease /</subfield><subfield code="c">edited by Heinrich Resch.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (164 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Many heterogeneous causes (e.g., metabolic, inflammatory, autoimmune, vascular, and renal diseases, and even drugs), collectively grouped as secondary causes of osteoporosis, may lead to bone loss or damage to architecture through a number of mechanisms. Although these secondary causes of osteoporosis are the most frequently observed causes of unexpected bone loss, they can only be diagnosed via a high degree of suspicion and clinical experience and by performing the appropriate investigations. In inflammatory disorders such as rheumatoid arthritis or chronic inflammatory bowel diseases, as well as vascular diseases, T-cell activation, and consequently pro-inflammatory cascades, trigger the increased expression of T-cell-derived RANKL. In addition, a new biomarker signature of bone-related miRNAs is promising in certain clinical features. Glucocorticoids, often used to control disease activity, decrease the number and function of osteoblasts and inhibit OPG expression. The ubiquitous occurrence of disease-related secondary changes in bone metabolism implies that numerous medical disciplines need to interact. Screening for secondary causes of osteoporosis and the search for new modes of action should present a substantial aspect of osteoporosis manageme.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bones</subfield><subfield code="x">Metabolism</subfield><subfield code="x">Disorders.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Osteoporosis</subfield><subfield code="x">Genetic aspects.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-6348-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Resch, Heinrich,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:05:36 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-04-02 14:12:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345669070004498&Force_direct=true</subfield><subfield code="Z">5345669070004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345669070004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345555030004498&Force_direct=true</subfield><subfield code="Z">5345555030004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345555030004498</subfield></datafield></record></collection> |